Impact on liver and metabolic health. For the twenty-six patients who had data available at 6 months (Supplemental Table S1, http://links.lww.com/HC9/B890), several improvements were noted (Supplemental Figure S1, http://links.lww.com/HC9/B890), both for liver health, including 39% (n=10) achieved clinically meaningful reduction in ALT,9 and metabolic health: 79% of patients (n=21) achieved A1c <7%, 72% LDL <100 mg/dL (69% of patients with diabetes), 50% SBP ≤130 mm Hg, 35% achieved guideline-based amounts of weekly physical activity and 26% body weight loss of ≥5%. Here, GPT is linked to diabetes mellitus.